4-54263747-T-C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_006206.6(PDGFRA):c.448T>C(p.Cys150Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006206.6 missense
Scores
Clinical Significance
Conservation
Publications
- gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
 - polyps, multiple and recurrent inflammatory fibroid, gastrointestinalInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P
 - congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
 - isolated cleft palateInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| PDGFRA | ENST00000257290.10  | c.448T>C | p.Cys150Arg | missense_variant | Exon 4 of 23 | 1 | NM_006206.6 | ENSP00000257290.5 | ||
| ENSG00000282278 | ENST00000507166.5  | c.1018-11178T>C | intron_variant | Intron 12 of 23 | 2 | ENSP00000423325.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00000657  AC: 1AN: 152164Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome Cov.: 33 
GnomAD4 genome   AF:  0.00000657  AC: 1AN: 152164Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74334 show subpopulations 
ClinVar
Submissions by phenotype
Gastrointestinal stromal tumor    Uncertain:1 
This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with PDGFRA-related disease. This sequence change replaces cysteine with arginine at codon 150 of the PDGFRA protein (p.Cys150Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine. -
Hereditary cancer-predisposing syndrome    Uncertain:1 
The p.C150R variant (also known as c.448T>C), located in coding exon 3 of the PDGFRA gene, results from a T to C substitution at nucleotide position 448. The cysteine at codon 150 is replaced by arginine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at